全文获取类型
收费全文 | 2345篇 |
免费 | 281篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 105篇 |
妇产科学 | 59篇 |
基础医学 | 343篇 |
口腔科学 | 32篇 |
临床医学 | 294篇 |
内科学 | 362篇 |
皮肤病学 | 39篇 |
神经病学 | 258篇 |
特种医学 | 164篇 |
外科学 | 414篇 |
综合类 | 58篇 |
一般理论 | 1篇 |
预防医学 | 200篇 |
眼科学 | 8篇 |
药学 | 187篇 |
中国医学 | 5篇 |
肿瘤学 | 96篇 |
出版年
2021年 | 38篇 |
2020年 | 22篇 |
2019年 | 39篇 |
2018年 | 48篇 |
2017年 | 31篇 |
2016年 | 31篇 |
2015年 | 49篇 |
2014年 | 53篇 |
2013年 | 79篇 |
2012年 | 78篇 |
2011年 | 64篇 |
2010年 | 62篇 |
2009年 | 72篇 |
2008年 | 73篇 |
2007年 | 81篇 |
2006年 | 83篇 |
2005年 | 79篇 |
2004年 | 89篇 |
2003年 | 64篇 |
2002年 | 67篇 |
2001年 | 84篇 |
2000年 | 70篇 |
1999年 | 59篇 |
1998年 | 49篇 |
1997年 | 53篇 |
1996年 | 56篇 |
1995年 | 49篇 |
1994年 | 45篇 |
1993年 | 52篇 |
1992年 | 61篇 |
1991年 | 52篇 |
1990年 | 42篇 |
1989年 | 56篇 |
1988年 | 62篇 |
1987年 | 46篇 |
1986年 | 49篇 |
1985年 | 43篇 |
1984年 | 35篇 |
1983年 | 37篇 |
1982年 | 35篇 |
1981年 | 28篇 |
1980年 | 25篇 |
1979年 | 34篇 |
1978年 | 39篇 |
1977年 | 30篇 |
1976年 | 29篇 |
1975年 | 25篇 |
1974年 | 21篇 |
1973年 | 18篇 |
1972年 | 16篇 |
排序方式: 共有2630条查询结果,搜索用时 15 毫秒
81.
82.
Bruce D. McCarthy MD MPH Marianne Ulcickas Yood MPH Mary Beth Bolton MD Emily A. Boohaker MD Cynthia H. MacWilliam MBA Mark J. Young MD 《Journal of general internal medicine》1997,12(6):357-363
OBJECTIVE: To develop, within the framework of continuous quality improvement, new processes for offering mammography and
determine whether protocols executed completely by nonphysicians would increase mammography utilization. DESIGN: A prospective
follow-up study with patients from an intervention clinic and two control clinics. SETTING: Three general internal medicine
clinics in a large, urban teaching hospital in Detroit, Michigan. PATIENTS/PARTICIPANTS: A total of 5,934 women, aged 40 through
75 years, making 16,546 visits to one of the clinics during the study period (September 1, 1992, through November 31, 1993).
INTERVENTION: Medical assistants and licensed practical nurses in the intervention clinic were trained to identify women due
for screening mammography, and to directly offer and order a mammogram if patients agreed. MEASUREMENTS AND MAIN RESULTS:
Patients were considered up-to-date with screening if they had a mammogram within 1 year (if age 50-75) or 2 years (if age
40-49) prior to the visit or a mammogram within 60 days after the visit. The proportion of visits each month in which a woman
was up-to-date with mammography was calculated using computerized billing records. Prior to the intervention, the proportion
of visits in which women were up-to-date was 68% (95% confidence interval [CI] 63%, 73%) in the intervention clinic and 66%
(95% CI 61%, 71%) in each of the control clinics. At the end of the evaluation, there was an absolute increase of 9% (95%
CI 2%, 16%) in the intervention clinic, and a difference of 1% (95% CI -5%, 7%) in one of the control clinics and -2% (95%
CI -3%, 5%) in the other. In the intervention clinic, the proportion of visits in which women were up-to-date with mammography
increased over time and was consistent with a linear trend (p = .004). CONCLUSIONS: Redesigning clinic processes to make offering
of mammography by medical assistants and licensed practical nurses a routine part of the clinic encounter can lead to mammography
rates that are superior to those seen in physicians' usual practice, even when screening levels are already fairly high. Physicians
need not be considered the sole, or even the primary, member of the health care team who can effectively deliver some preventive
health measures. 相似文献
83.
Background
The Health Information Technology for Economic and Clinical Health (HITECH) Act imposes pressure on health care organizations to qualify for “Meaningful Use”. It is assumed that portals should increase patient participation in medical decisions, but whether or not the use of portals improves outcomes remains to be seen.Objective
The purpose of this systemic review is to outline and summarize study results on the effect of patient portals on quality, or chronic-condition outcomes as defined by the Agency for Healthcare Research and Quality, and its implications to Meaningful Use since the beginning of 2011. This review updates and builds on the work by Ammenwerth, Schnell-Inderst, and Hoerbst.Methods
We performed a systematic literature search in PubMed, CINAHL, and Google Scholar. We identified any data-driven study, quantitative or qualitative, that examined a relationship between patient portals, or patient portal features, and outcomes. We also wanted to relate the findings back to Meaningful Use criteria. Over 4000 articles were screened, and 27 were analyzed and summarized for this systematic review.Results
We identified 26 studies and 1 review, and we summarized their findings and applicability to our research question. Very few studies associated use of the patient portal, or its features, to improved outcomes; 37% (10/27) of papers reported improvements in medication adherence, disease awareness, self-management of disease, a decrease of office visits, an increase in preventative medicine, and an increase in extended office visits, at the patient’s request for additional information. The results also show an increase in quality in terms of patient satisfaction and customer retention, but there are weak results on medical outcomes.Conclusions
The results of this review demonstrate that more health care organizations today offer features of a patient portal than in the review published in 2011. Articles reviewed rarely analyzed a full patient portal but instead analyzed features of a portal such as secure messaging, as well as disease management and monitoring. The ability of patients to be able to view their health information electronically meets the intent of Meaningful Use, Stage 2 requirements, but the ability to transmit to a third party was not found in the review. 相似文献84.
Anal cancer is one of the most common non‐AIDS‐defining malignancies in the era of combination antiretroviral therapy. Its precursor lesion, anal intraepithelial neoplasia (AIN), is highly prevalent in HIV‐infected populations. More than 90% of anal squamous cell cancers are attributable to human papillomavirus (HPV). While the biology of HPV‐related intraepithelial neoplasia is consistent across lower anogenital sites, the natural history of AIN is not well established and cannot be assumed to be identical to that of cervical intraepithelial neoplasia. Screening strategies to prevent anal cancer should be developed based on robust natural history data in HIV‐infected and uninfected populations. Likewise, treatments need to be tested in randomized clinical trials, and reserved for those at significant risk of progression to cancer. This review covers the epidemiology, pathogenesis and immunology of HPV infection, AIN and anal cancer, and summarizes the current diagnosis, screening and treatment strategies in HIV‐infected adults. 相似文献
85.
86.
Tomato immune receptor Ve1 recognizes effector of multiple fungal pathogens uncovered by genome and RNA sequencing 总被引:5,自引:0,他引:5
87.
Nieborowska-Skorska M Kopinski PK Ray R Hoser G Ngaba D Flis S Cramer K Reddy MM Koptyra M Penserga T Glodkowska-Mrowka E Bolton E Holyoake TL Eaves CJ Cerny-Reiterer S Valent P Hochhaus A Hughes TP van der Kuip H Sattler M Wiktor-Jedrzejczak W Richardson C Dorrance A Stoklosa T Williams DA Skorski T 《Blood》2012,119(18):4253-4263
Chronic myeloid leukemia in chronic phase (CML-CP) is induced by BCR-ABL1 oncogenic tyrosine kinase. Tyrosine kinase inhibitors eliminate the bulk of CML-CP cells, but fail to eradicate leukemia stem cells (LSCs) and leukemia progenitor cells (LPCs) displaying innate and acquired resistance, respectively. These cells may accumulate genomic instability, leading to disease relapse and/or malignant progression to a fatal blast phase. In the present study, we show that Rac2 GTPase alters mitochondrial membrane potential and electron flow through the mitochondrial respiratory chain complex III (MRC-cIII), thereby generating high levels of reactive oxygen species (ROS) in CML-CP LSCs and primitive LPCs. MRC-cIII-generated ROS promote oxidative DNA damage to trigger genomic instability, resulting in an accumulation of chromosomal aberrations and tyrosine kinase inhibitor-resistant BCR-ABL1 mutants. JAK2(V617F) and FLT3(ITD)-positive polycythemia vera cells and acute myeloid leukemia cells also produce ROS via MRC-cIII. In the present study, inhibition of Rac2 by genetic deletion or a small-molecule inhibitor and down-regulation of mitochondrial ROS by disruption of MRC-cIII, expression of mitochondria-targeted catalase, or addition of ROS-scavenging mitochondria-targeted peptide aptamer reduced genomic instability. We postulate that the Rac2-MRC-cIII pathway triggers ROS-mediated genomic instability in LSCs and primitive LPCs, which could be targeted to prevent the relapse and malignant progression of CML. 相似文献
88.
89.
Wound care professionals can improve clinical, patient-oriented wound outcomes and do so cost-effectively by using scientific evidence to meet patient and wound care goals and needs. A review of the literature was conducted to define evidence-based wound management, describe the potential of science to improve outcomes in wound care, and sum- marize strategies, tactics, and tools for wound care providers and recipients to utilize science to their mutual benefit. In addition, changes in the availability of randomized and nonrandomized and clinical and preclinical evidence during the past 50 years were examined using MEDLINE database searches of English-language publications, combining the search terms wound, ulcer, or burn limited by the terms randomized or clinical for each decade since 1960. The number of published, nonrandomized wound studies has increased exponentially during the last five decades but, more recently, evidence from randomized controlled trials also has become available. Moreover, while many questions remain unan- swered, a substantial number of publications have shown the use of available evidence-based guidelines and wound care strategies improves outcomes of care while saving time and money. The application of science-based wound care in clinical practice is increasing slowly; expensive techniques supported by limited or inconsistent evidence are still in use and add to wound care costs without certainty they improve outcomes. The literature provides compelling evidence that patients with a wide variety of diagnoses benefit when opinion-based care is replaced by clinical wisdom applied on a substrate of best available evidence. Patients with wounds deserve no less. 相似文献